CCIA
XENT

Campbell & Co Investment Adviser’s Intersect ENT, Inc XENT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6,470
Closed -$242K – 563
2018
Q2 		$242K Buy
+6,470
New +$254K 0.19% 259
2018
Q1 		– Sell
-9,599
Closed -$311K – 565
2017
Q4 		$311K Buy
9,599
+2,282
+31% +$68.4K 0.23% 175
2017
Q3 		$228K Buy
+7,317
New +$217K 0.18% 253

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Campbell & Co Investment Adviser's XENT Position: Q3 2018 in Review

Campbell & Co Investment Adviser sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 6,470 shares — an estimated $242K sold.

Campbell & Co Investment Adviser first reported a position in XENT in Q3 2017 and held it in 3 quarters. The position peaked at $311K in Q4 2017. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Campbell & Co Investment Adviser reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 6,470 Intersect ENT, Inc shares in Q3 2018, an estimated $242K.
  • Campbell & Co Investment Adviser first reported a position in Intersect ENT, Inc in Q3 2017 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Intersect ENT, Inc position peaked at $311K in Q4 2017.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2018, filed 8 Nov 2018.